 Jacob Friedman
Concepts (453)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 35 | 2023 | 2508 | 5.170 |
Why?
| | Diabetes, Gestational | 18 | 2023 | 281 | 3.970 |
Why?
| | Non-alcoholic Fatty Liver Disease | 11 | 2023 | 245 | 3.190 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 11 | 2018 | 32 | 3.170 |
Why?
| | Maternal Nutritional Physiological Phenomena | 11 | 2021 | 141 | 2.970 |
Why?
| | Fatty Liver | 12 | 2014 | 211 | 2.920 |
Why?
| | Prenatal Exposure Delayed Effects | 13 | 2020 | 452 | 2.850 |
Why?
| | Liver | 22 | 2023 | 1637 | 2.340 |
Why?
| | Adiposity | 14 | 2023 | 458 | 2.340 |
Why?
| | Pregnancy | 60 | 2023 | 5518 | 2.130 |
Why?
| | Muscle, Skeletal | 15 | 2020 | 1473 | 1.990 |
Why?
| | Diet, High-Fat | 8 | 2022 | 225 | 1.520 |
Why?
| | Insulin | 25 | 2022 | 2080 | 1.390 |
Why?
| | Insulin Resistance | 14 | 2023 | 1072 | 1.370 |
Why?
| | Fatty Acids | 5 | 2017 | 381 | 1.360 |
Why?
| | Pregnancy Complications | 7 | 2018 | 429 | 1.320 |
Why?
| | Fetus | 10 | 2023 | 700 | 1.320 |
Why?
| | Gastrointestinal Microbiome | 4 | 2020 | 501 | 1.320 |
Why?
| | Adipogenesis | 4 | 2017 | 42 | 1.240 |
Why?
| | Bone Marrow | 2 | 2023 | 243 | 1.240 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 5 | 2017 | 57 | 1.210 |
Why?
| | Birth Weight | 7 | 2020 | 440 | 1.200 |
Why?
| | Lipid Metabolism | 14 | 2023 | 444 | 1.170 |
Why?
| | Fetal Development | 5 | 2018 | 246 | 1.080 |
Why?
| | Epigenesis, Genetic | 5 | 2016 | 520 | 1.020 |
Why?
| | Oxidative Stress | 9 | 2022 | 1076 | 1.010 |
Why?
| | DNA Methylation | 6 | 2023 | 495 | 0.990 |
Why?
| | Glucose | 12 | 2023 | 897 | 0.990 |
Why?
| | Fetal Growth Retardation | 8 | 2019 | 467 | 0.940 |
Why?
| | Microbiota | 4 | 2022 | 647 | 0.930 |
Why?
| | Inflammation | 10 | 2018 | 2480 | 0.930 |
Why?
| | Diet, Western | 6 | 2023 | 66 | 0.920 |
Why?
| | AMP-Activated Protein Kinases | 4 | 2023 | 172 | 0.910 |
Why?
| | Animals | 51 | 2023 | 31706 | 0.890 |
Why?
| | Female | 70 | 2023 | 59511 | 0.880 |
Why?
| | Sirtuin 3 | 3 | 2013 | 52 | 0.850 |
Why?
| | Dietary Fats | 4 | 2017 | 287 | 0.850 |
Why?
| | Energy Metabolism | 8 | 2019 | 731 | 0.830 |
Why?
| | PPAR gamma | 5 | 2017 | 182 | 0.810 |
Why?
| | Macrophages | 6 | 2016 | 1263 | 0.810 |
Why?
| | Umbilical Cord | 3 | 2017 | 80 | 0.780 |
Why?
| | Mitochondria | 7 | 2020 | 747 | 0.770 |
Why?
| | Breast Feeding | 3 | 2020 | 368 | 0.760 |
Why?
| | Gluconeogenesis | 8 | 2018 | 62 | 0.750 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 3 | 2012 | 32 | 0.740 |
Why?
| | Infant, Newborn | 17 | 2023 | 5047 | 0.730 |
Why?
| | Fatty Acids, Omega-3 | 3 | 2022 | 122 | 0.710 |
Why?
| | Hematopoietic Stem Cells | 1 | 2023 | 343 | 0.690 |
Why?
| | Infant Formula | 1 | 2020 | 74 | 0.690 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2020 | 97 | 0.680 |
Why?
| | Fatty Acid Desaturases | 1 | 2020 | 29 | 0.670 |
Why?
| | Maternal Exposure | 2 | 2021 | 138 | 0.660 |
Why?
| | Transgenes | 1 | 2020 | 170 | 0.650 |
Why?
| | Amino Acids | 4 | 2017 | 448 | 0.630 |
Why?
| | Mothers | 6 | 2018 | 651 | 0.630 |
Why?
| | Endoplasmic Reticulum | 3 | 2010 | 234 | 0.620 |
Why?
| | PQQ Cofactor | 2 | 2022 | 5 | 0.610 |
Why?
| | Macrophage Activation | 3 | 2014 | 164 | 0.590 |
Why?
| | Muscle Proteins | 2 | 2014 | 210 | 0.590 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2020 | 180 | 0.590 |
Why?
| | Mice | 21 | 2020 | 14869 | 0.580 |
Why?
| | Triglycerides | 8 | 2023 | 467 | 0.570 |
Why?
| | Diet | 5 | 2022 | 1080 | 0.570 |
Why?
| | Pediatric Obesity | 3 | 2022 | 489 | 0.570 |
Why?
| | Fatty Acids, Omega-6 | 2 | 2017 | 45 | 0.570 |
Why?
| | Adenylate Kinase | 3 | 2014 | 26 | 0.560 |
Why?
| | Metabolic Diseases | 2 | 2017 | 98 | 0.550 |
Why?
| | Gene Expression Regulation | 9 | 2019 | 2320 | 0.550 |
Why?
| | Blood Glucose | 11 | 2023 | 1828 | 0.540 |
Why?
| | Hyperlipidemias | 2 | 2016 | 121 | 0.540 |
Why?
| | Phosphatidylinositol 3-Kinases | 3 | 2012 | 329 | 0.530 |
Why?
| | Niacinamide | 1 | 2016 | 63 | 0.520 |
Why?
| | Humans | 56 | 2023 | 114689 | 0.520 |
Why?
| | Adipose Tissue | 5 | 2018 | 545 | 0.520 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2015 | 77 | 0.500 |
Why?
| | Infant | 11 | 2022 | 7963 | 0.490 |
Why?
| | Mitochondrial Proteins | 2 | 2014 | 219 | 0.490 |
Why?
| | Metabolomics | 3 | 2017 | 521 | 0.480 |
Why?
| | Gene Expression | 3 | 2017 | 1421 | 0.470 |
Why?
| | Antioxidants | 2 | 2023 | 530 | 0.460 |
Why?
| | Cholesterol | 1 | 2016 | 367 | 0.460 |
Why?
| | Fenofibrate | 2 | 2016 | 24 | 0.460 |
Why?
| | Placenta | 5 | 2021 | 626 | 0.450 |
Why?
| | beta Catenin | 1 | 2015 | 219 | 0.450 |
Why?
| | Insulin Receptor Substrate Proteins | 4 | 2011 | 56 | 0.450 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2022 | 2096 | 0.440 |
Why?
| | Carcinoma, Hepatocellular | 3 | 2010 | 211 | 0.440 |
Why?
| | Electron Transport Complex II | 1 | 2013 | 23 | 0.440 |
Why?
| | Phosphoenolpyruvate Carboxykinase (ATP) | 2 | 2010 | 15 | 0.430 |
Why?
| | Hepacivirus | 2 | 2012 | 229 | 0.430 |
Why?
| | Macaca | 4 | 2018 | 50 | 0.430 |
Why?
| | Orphan Nuclear Receptors | 1 | 2012 | 14 | 0.420 |
Why?
| | Hydrocarbons, Fluorinated | 1 | 2012 | 9 | 0.420 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 801 | 0.410 |
Why?
| | Calcium Signaling | 1 | 2014 | 217 | 0.410 |
Why?
| | Mitochondria, Liver | 1 | 2012 | 67 | 0.410 |
Why?
| | Class Ia Phosphatidylinositol 3-Kinase | 1 | 2012 | 7 | 0.410 |
Why?
| | Atherosclerosis | 1 | 2016 | 341 | 0.400 |
Why?
| | Hypoxia | 1 | 2018 | 958 | 0.400 |
Why?
| | Adipose Tissue, Brown | 1 | 2012 | 43 | 0.400 |
Why?
| | Viral Nonstructural Proteins | 1 | 2012 | 54 | 0.400 |
Why?
| | Genome, Viral | 1 | 2012 | 118 | 0.390 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 306 | 0.380 |
Why?
| | MicroRNAs | 2 | 2020 | 600 | 0.370 |
Why?
| | Sheep | 8 | 2023 | 764 | 0.370 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2011 | 36 | 0.370 |
Why?
| | Anticholesteremic Agents | 1 | 2012 | 128 | 0.360 |
Why?
| | Glucose Tolerance Test | 6 | 2018 | 343 | 0.360 |
Why?
| | Signal Transduction | 12 | 2020 | 4513 | 0.360 |
Why?
| | Male | 23 | 2020 | 55599 | 0.350 |
Why?
| | Metformin | 3 | 2023 | 276 | 0.340 |
Why?
| | Pre-Eclampsia | 1 | 2012 | 165 | 0.340 |
Why?
| | Lipids | 5 | 2017 | 580 | 0.340 |
Why?
| | Phosphorylation | 8 | 2021 | 1569 | 0.340 |
Why?
| | Hyperglycemia | 2 | 2020 | 292 | 0.330 |
Why?
| | Receptors, Adiponectin | 1 | 2009 | 15 | 0.330 |
Why?
| | Glucose Intolerance | 1 | 2011 | 136 | 0.330 |
Why?
| | Liver Neoplasms | 2 | 2010 | 506 | 0.330 |
Why?
| | Phenylbutyrates | 1 | 2009 | 21 | 0.330 |
Why?
| | Adult | 22 | 2022 | 30550 | 0.330 |
Why?
| | Body Mass Index | 8 | 2022 | 1959 | 0.330 |
Why?
| | RNA, Messenger | 6 | 2017 | 2553 | 0.330 |
Why?
| | Sulfonamides | 1 | 2012 | 445 | 0.320 |
Why?
| | Biomarkers | 8 | 2023 | 3408 | 0.310 |
Why?
| | Dietary Supplements | 5 | 2022 | 460 | 0.300 |
Why?
| | Up-Regulation | 2 | 2010 | 808 | 0.300 |
Why?
| | Primates | 3 | 2023 | 111 | 0.290 |
Why?
| | Diet, Fat-Restricted | 3 | 2023 | 73 | 0.290 |
Why?
| | Haplorhini | 2 | 2018 | 57 | 0.280 |
Why?
| | Mice, Inbred C57BL | 6 | 2018 | 4694 | 0.280 |
Why?
| | Mammary Glands, Human | 2 | 2020 | 60 | 0.270 |
Why?
| | Oxidation-Reduction | 4 | 2017 | 923 | 0.260 |
Why?
| | Carnitine | 2 | 2017 | 62 | 0.260 |
Why?
| | Postprandial Period | 3 | 2018 | 87 | 0.260 |
Why?
| | Preconception Care | 2 | 2018 | 31 | 0.260 |
Why?
| | Lactation | 2 | 2020 | 149 | 0.260 |
Why?
| | Muscle Development | 2 | 2017 | 98 | 0.260 |
Why?
| | Electron Transport | 2 | 2017 | 108 | 0.260 |
Why?
| | Milk, Human | 2 | 2020 | 127 | 0.260 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2007 | 1140 | 0.250 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 3 | 2012 | 127 | 0.250 |
Why?
| | Cytokines | 6 | 2018 | 1841 | 0.250 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 3 | 2012 | 144 | 0.250 |
Why?
| | Enzyme Activation | 3 | 2012 | 785 | 0.240 |
Why?
| | Amino Acids, Branched-Chain | 2 | 2018 | 31 | 0.240 |
Why?
| | Diet, Diabetic | 2 | 2015 | 33 | 0.240 |
Why?
| | Hepatocytes | 3 | 2023 | 195 | 0.230 |
Why?
| | Cell Line, Tumor | 5 | 2014 | 2710 | 0.230 |
Why?
| | Postpartum Period | 4 | 2020 | 278 | 0.220 |
Why?
| | Lipoprotein Lipase | 2 | 2018 | 54 | 0.220 |
Why?
| | Glucokinase | 1 | 2003 | 13 | 0.220 |
Why?
| | Mice, Knockout | 6 | 2014 | 2570 | 0.220 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2016 | 144 | 0.220 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2003 | 44 | 0.220 |
Why?
| | Prolactin | 1 | 2003 | 96 | 0.220 |
Why?
| | Cyclic AMP | 1 | 2003 | 227 | 0.210 |
Why?
| | Blotting, Western | 5 | 2019 | 1147 | 0.210 |
Why?
| | Bifidobacterium | 1 | 2022 | 21 | 0.200 |
Why?
| | Glucose Clamp Technique | 3 | 2019 | 181 | 0.200 |
Why?
| | Longitudinal Studies | 3 | 2020 | 2387 | 0.200 |
Why?
| | Progesterone | 1 | 2003 | 232 | 0.200 |
Why?
| | Glycerol | 1 | 2022 | 84 | 0.200 |
Why?
| | Mice, Transgenic | 2 | 2020 | 1949 | 0.200 |
Why?
| | Cell Differentiation | 4 | 2017 | 1701 | 0.190 |
Why?
| | Insulins | 1 | 2022 | 32 | 0.190 |
Why?
| | Forkhead Transcription Factors | 2 | 2012 | 170 | 0.190 |
Why?
| | Dexamethasone | 1 | 2003 | 317 | 0.190 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2021 | 9 | 0.180 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2021 | 18 | 0.180 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2021 | 42 | 0.180 |
Why?
| | Child | 9 | 2023 | 18415 | 0.180 |
Why?
| | Response Elements | 2 | 2011 | 82 | 0.180 |
Why?
| | Thapsigargin | 2 | 2010 | 18 | 0.170 |
Why?
| | Risk Factors | 6 | 2022 | 8632 | 0.170 |
Why?
| | Liver Cirrhosis | 1 | 2021 | 227 | 0.170 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2021 | 260 | 0.170 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 5 | 2019 | 923 | 0.170 |
Why?
| | Body Composition | 5 | 2017 | 590 | 0.170 |
Why?
| | Phenotype | 4 | 2023 | 2796 | 0.160 |
Why?
| | Carnitine O-Palmitoyltransferase | 2 | 2017 | 43 | 0.160 |
Why?
| | Immune System | 1 | 2020 | 172 | 0.160 |
Why?
| | Diabetes Mellitus | 1 | 2007 | 900 | 0.160 |
Why?
| | Promoter Regions, Genetic | 3 | 2017 | 1131 | 0.160 |
Why?
| | Germ-Free Life | 1 | 2018 | 28 | 0.160 |
Why?
| | Culture Media, Conditioned | 2 | 2016 | 105 | 0.160 |
Why?
| | Citric Acid Cycle | 1 | 2018 | 43 | 0.160 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2021 | 286 | 0.160 |
Why?
| | Fatty Acids, Volatile | 1 | 2018 | 47 | 0.150 |
Why?
| | Gene Expression Profiling | 4 | 2019 | 1518 | 0.150 |
Why?
| | PPAR alpha | 3 | 2022 | 52 | 0.150 |
Why?
| | Rats | 4 | 2012 | 4958 | 0.150 |
Why?
| | Fetal Macrosomia | 1 | 2018 | 58 | 0.150 |
Why?
| | Micronutrients | 1 | 2018 | 78 | 0.150 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2017 | 33 | 0.150 |
Why?
| | Islets of Langerhans | 1 | 2003 | 726 | 0.140 |
Why?
| | Bile Acids and Salts | 1 | 2018 | 171 | 0.140 |
Why?
| | Immunity, Innate | 1 | 2023 | 720 | 0.140 |
Why?
| | Niacin | 1 | 2017 | 18 | 0.140 |
Why?
| | Muscle Cells | 1 | 2017 | 42 | 0.140 |
Why?
| | Hypoglycemic Agents | 3 | 2018 | 1013 | 0.140 |
Why?
| | Bone Marrow Cells | 2 | 2016 | 267 | 0.140 |
Why?
| | Dysbiosis | 1 | 2018 | 146 | 0.140 |
Why?
| | Mitochondrial Diseases | 1 | 2017 | 77 | 0.140 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2020 | 398 | 0.140 |
Why?
| | Caenorhabditis elegans | 1 | 2020 | 268 | 0.140 |
Why?
| | Computational Biology | 1 | 2020 | 530 | 0.140 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2016 | 157 | 0.130 |
Why?
| | Mice, Knockout, ApoE | 1 | 2016 | 8 | 0.130 |
Why?
| | Sirtuin 1 | 1 | 2016 | 29 | 0.130 |
Why?
| | Foam Cells | 1 | 2016 | 13 | 0.130 |
Why?
| | Myoblasts | 1 | 2017 | 76 | 0.130 |
Why?
| | Gestational Age | 5 | 2019 | 760 | 0.130 |
Why?
| | Feces | 1 | 2018 | 373 | 0.130 |
Why?
| | Ceramides | 1 | 2016 | 91 | 0.130 |
Why?
| | Colitis | 1 | 2018 | 223 | 0.130 |
Why?
| | RAW 264.7 Cells | 1 | 2016 | 41 | 0.130 |
Why?
| | Plethysmography | 1 | 2016 | 103 | 0.130 |
Why?
| | Cyclooxygenase 2 | 1 | 2016 | 164 | 0.130 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2018 | 339 | 0.130 |
Why?
| | Nutritional Status | 2 | 2018 | 287 | 0.130 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2015 | 60 | 0.130 |
Why?
| | Cohort Studies | 3 | 2015 | 4895 | 0.130 |
Why?
| | Gene Deletion | 2 | 2018 | 356 | 0.130 |
Why?
| | Interleukin-6 | 2 | 2016 | 676 | 0.130 |
Why?
| | Cells, Cultured | 4 | 2016 | 3886 | 0.120 |
Why?
| | Gene Silencing | 1 | 2016 | 171 | 0.120 |
Why?
| | Adolescent | 7 | 2023 | 17848 | 0.120 |
Why?
| | 3T3-L1 Cells | 2 | 2012 | 31 | 0.120 |
Why?
| | Glucose-6-Phosphatase | 2 | 2012 | 31 | 0.120 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2016 | 185 | 0.120 |
Why?
| | Space Flight | 1 | 2016 | 127 | 0.120 |
Why?
| | Hematopoiesis | 1 | 2016 | 171 | 0.120 |
Why?
| | Cell Division | 1 | 2017 | 758 | 0.120 |
Why?
| | Young Adult | 7 | 2018 | 10470 | 0.120 |
Why?
| | Awards and Prizes | 1 | 2015 | 56 | 0.120 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2018 | 284 | 0.120 |
Why?
| | Bacteria | 1 | 2020 | 725 | 0.120 |
Why?
| | Endocrinology | 1 | 2015 | 70 | 0.120 |
Why?
| | Maternal Welfare | 1 | 2014 | 14 | 0.110 |
Why?
| | Overweight | 2 | 2015 | 472 | 0.110 |
Why?
| | Glucose Transporter Type 4 | 2 | 2006 | 36 | 0.110 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 797 | 0.110 |
Why?
| | Animal Feed | 1 | 2014 | 49 | 0.110 |
Why?
| | Maternal-Fetal Exchange | 1 | 2015 | 151 | 0.110 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 532 | 0.110 |
Why?
| | Disease Progression | 1 | 2020 | 2380 | 0.110 |
Why?
| | Nutrition Assessment | 1 | 2014 | 75 | 0.110 |
Why?
| | Body Weight | 4 | 2016 | 869 | 0.110 |
Why?
| | Dietary Fiber | 1 | 2013 | 40 | 0.110 |
Why?
| | Disease Models, Animal | 3 | 2019 | 3535 | 0.110 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 993 | 0.110 |
Why?
| | Intestines | 2 | 2013 | 326 | 0.110 |
Why?
| | Dietary Carbohydrates | 1 | 2014 | 138 | 0.110 |
Why?
| | Sheep, Domestic | 2 | 2019 | 33 | 0.110 |
Why?
| | Cell Proliferation | 2 | 2017 | 2187 | 0.110 |
Why?
| | Liver X Receptors | 1 | 2012 | 30 | 0.100 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2018 | 959 | 0.100 |
Why?
| | MAP Kinase Kinase 4 | 1 | 2012 | 23 | 0.100 |
Why?
| | Forkhead Box Protein O1 | 1 | 2012 | 15 | 0.100 |
Why?
| | Adipocytes | 2 | 2017 | 188 | 0.100 |
Why?
| | Secretory Vesicles | 1 | 2012 | 24 | 0.100 |
Why?
| | Enzyme Induction | 1 | 2012 | 84 | 0.100 |
Why?
| | Antigens, Differentiation | 1 | 2012 | 79 | 0.100 |
Why?
| | Lipogenesis | 1 | 2012 | 56 | 0.100 |
Why?
| | Mice, Mutant Strains | 1 | 2012 | 271 | 0.100 |
Why?
| | Luciferases | 1 | 2012 | 142 | 0.100 |
Why?
| | Transcription Factor RelA | 1 | 2012 | 82 | 0.100 |
Why?
| | Endotoxins | 2 | 2023 | 211 | 0.100 |
Why?
| | Cholesterol, HDL | 1 | 2012 | 183 | 0.100 |
Why?
| | Glutathione | 1 | 2013 | 293 | 0.100 |
Why?
| | Genes, Reporter | 1 | 2012 | 257 | 0.100 |
Why?
| | Colorado | 2 | 2020 | 4099 | 0.100 |
Why?
| | Receptor, Insulin | 4 | 2007 | 93 | 0.100 |
Why?
| | Prenatal Care | 1 | 2014 | 253 | 0.100 |
Why?
| | Retinoid X Receptor alpha | 1 | 2011 | 4 | 0.100 |
Why?
| | Risk Assessment | 1 | 2020 | 2968 | 0.100 |
Why?
| | Membrane Proteins | 1 | 2017 | 1019 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 159 | 0.090 |
Why?
| | Random Allocation | 3 | 2023 | 335 | 0.090 |
Why?
| | Proteomics | 2 | 2014 | 836 | 0.090 |
Why?
| | Inflammasomes | 1 | 2012 | 115 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 1727 | 0.090 |
Why?
| | Practice Guidelines as Topic | 1 | 2018 | 1395 | 0.090 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2012 | 473 | 0.090 |
Why?
| | NAD | 1 | 2011 | 63 | 0.090 |
Why?
| | Hydrocortisone | 1 | 2012 | 267 | 0.090 |
Why?
| | Adipocytes, White | 1 | 2010 | 17 | 0.090 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2011 | 184 | 0.090 |
Why?
| | Interleukin-10 | 1 | 2012 | 299 | 0.090 |
Why?
| | Serine | 1 | 2011 | 126 | 0.090 |
Why?
| | Virus Replication | 1 | 2012 | 395 | 0.090 |
Why?
| | Tyrosine | 1 | 2011 | 214 | 0.090 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2011 | 270 | 0.080 |
Why?
| | Caloric Restriction | 1 | 2011 | 90 | 0.080 |
Why?
| | Cell Line | 2 | 2007 | 2637 | 0.080 |
Why?
| | Fibroblasts | 1 | 2014 | 838 | 0.080 |
Why?
| | Tunicamycin | 1 | 2009 | 11 | 0.080 |
Why?
| | Mesoderm | 1 | 2010 | 138 | 0.080 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 2009 | 34 | 0.080 |
Why?
| | Myeloid Cells | 1 | 2010 | 126 | 0.080 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 2009 | 38 | 0.080 |
Why?
| | CREB-Binding Protein | 1 | 2008 | 27 | 0.080 |
Why?
| | Cyclin D1 | 1 | 2008 | 61 | 0.080 |
Why?
| | Hypolipidemic Agents | 1 | 2009 | 86 | 0.080 |
Why?
| | Time Factors | 3 | 2012 | 6116 | 0.080 |
Why?
| | Animals, Newborn | 3 | 2017 | 778 | 0.080 |
Why?
| | Carrier Proteins | 1 | 2012 | 695 | 0.080 |
Why?
| | Child Development | 1 | 2012 | 385 | 0.080 |
Why?
| | Protein Binding | 2 | 2010 | 1890 | 0.070 |
Why?
| | Placental Insufficiency | 1 | 2009 | 102 | 0.070 |
Why?
| | Models, Genetic | 1 | 2010 | 562 | 0.070 |
Why?
| | Wnt Proteins | 1 | 2008 | 134 | 0.070 |
Why?
| | Choline Deficiency | 1 | 2007 | 11 | 0.070 |
Why?
| | Stress, Physiological | 1 | 2010 | 378 | 0.070 |
Why?
| | Cytochrome P-450 CYP2E1 | 1 | 2007 | 25 | 0.070 |
Why?
| | Acute-Phase Reaction | 1 | 2007 | 39 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2017 | 1842 | 0.070 |
Why?
| | eIF-2 Kinase | 1 | 2007 | 24 | 0.070 |
Why?
| | Palmitates | 1 | 2007 | 16 | 0.070 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2007 | 24 | 0.070 |
Why?
| | Histones | 1 | 2012 | 535 | 0.070 |
Why?
| | Age Factors | 2 | 2011 | 2894 | 0.070 |
Why?
| | Transcription Factor CHOP | 1 | 2007 | 28 | 0.070 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 1 | 2007 | 54 | 0.070 |
Why?
| | Lipase | 1 | 2007 | 55 | 0.070 |
Why?
| | Ribosomal Protein S6 Kinases | 2 | 2008 | 21 | 0.070 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2007 | 53 | 0.070 |
Why?
| | Fibrosis | 2 | 2023 | 453 | 0.070 |
Why?
| | Phosphoproteins | 3 | 2006 | 298 | 0.070 |
Why?
| | Hormones | 1 | 2007 | 132 | 0.070 |
Why?
| | Methionine | 1 | 2007 | 144 | 0.070 |
Why?
| | Adiponectin | 2 | 2018 | 213 | 0.070 |
Why?
| | Proteins | 1 | 2012 | 908 | 0.070 |
Why?
| | Glucose Transporter Type 1 | 1 | 2006 | 42 | 0.060 |
Why?
| | Reference Values | 1 | 2007 | 743 | 0.060 |
Why?
| | Pilot Projects | 2 | 2023 | 1373 | 0.060 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2086 | 0.060 |
Why?
| | Fasting | 2 | 2018 | 241 | 0.060 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2010 | 1141 | 0.060 |
Why?
| | RNA | 1 | 2011 | 809 | 0.060 |
Why?
| | Protein Kinase Inhibitors | 1 | 2010 | 785 | 0.060 |
Why?
| | Glycemic Index | 2 | 2015 | 21 | 0.060 |
Why?
| | Insulin Antagonists | 1 | 2003 | 6 | 0.060 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2015 | 151 | 0.060 |
Why?
| | Keto Acids | 1 | 2003 | 12 | 0.060 |
Why?
| | Hypertension, Pulmonary | 1 | 2014 | 1729 | 0.050 |
Why?
| | NF-kappa B | 1 | 2007 | 641 | 0.050 |
Why?
| | Leptin | 2 | 2018 | 210 | 0.050 |
Why?
| | Prospective Studies | 3 | 2022 | 6220 | 0.050 |
Why?
| | C-Peptide | 1 | 2023 | 138 | 0.050 |
Why?
| | Drug Synergism | 1 | 2003 | 316 | 0.050 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2020 | 358 | 0.050 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2020 | 1214 | 0.050 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2002 | 45 | 0.050 |
Why?
| | Fetal Blood | 1 | 2023 | 270 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 1 | 2012 | 3053 | 0.050 |
Why?
| | Mammals | 1 | 2023 | 244 | 0.050 |
Why?
| | Longevity | 1 | 2022 | 137 | 0.050 |
Why?
| | Aging | 1 | 2011 | 1618 | 0.050 |
Why?
| | Myocardium | 1 | 2006 | 913 | 0.050 |
Why?
| | Uterus | 1 | 2021 | 192 | 0.040 |
Why?
| | Skinfold Thickness | 1 | 2020 | 49 | 0.040 |
Why?
| | Models, Biological | 2 | 2010 | 1621 | 0.040 |
Why?
| | Follow-Up Studies | 2 | 2022 | 4411 | 0.040 |
Why?
| | Transcription Factors | 1 | 2007 | 1528 | 0.040 |
Why?
| | Patient Compliance | 2 | 2014 | 525 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 91 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2003 | 532 | 0.040 |
Why?
| | Proton Magnetic Resonance Spectroscopy | 1 | 2019 | 20 | 0.040 |
Why?
| | Biological Transport | 1 | 2020 | 373 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 188 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2021 | 1016 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2022 | 823 | 0.040 |
Why?
| | Protein Biosynthesis | 2 | 2012 | 386 | 0.040 |
Why?
| | Immunoglobulin G | 1 | 2022 | 770 | 0.040 |
Why?
| | Cell Membrane | 1 | 2002 | 680 | 0.040 |
Why?
| | Perilipin-1 | 1 | 2017 | 16 | 0.040 |
Why?
| | Treatment Outcome | 3 | 2018 | 9088 | 0.040 |
Why?
| | Pregnancy Trimester, First | 1 | 2018 | 125 | 0.040 |
Why?
| | Cell Size | 1 | 2017 | 80 | 0.040 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2017 | 60 | 0.040 |
Why?
| | Guatemala | 1 | 2018 | 266 | 0.040 |
Why?
| | Diet Surveys | 1 | 2017 | 78 | 0.040 |
Why?
| | Flow Cytometry | 1 | 2020 | 1083 | 0.030 |
Why?
| | Child, Preschool | 2 | 2021 | 9116 | 0.030 |
Why?
| | Obstetrics | 1 | 2018 | 146 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 546 | 0.030 |
Why?
| | Hepatic Stellate Cells | 1 | 2016 | 10 | 0.030 |
Why?
| | Lipid Droplets | 1 | 2016 | 21 | 0.030 |
Why?
| | Down-Regulation | 1 | 2018 | 594 | 0.030 |
Why?
| | Systems Biology | 1 | 2016 | 54 | 0.030 |
Why?
| | Lactates | 1 | 2015 | 79 | 0.030 |
Why?
| | Epithelial Cells | 1 | 2020 | 951 | 0.030 |
Why?
| | Energy Intake | 1 | 2017 | 427 | 0.030 |
Why?
| | Societies, Medical | 1 | 2018 | 664 | 0.030 |
Why?
| | Rats, Inbred WKY | 1 | 2014 | 32 | 0.030 |
Why?
| | Health | 1 | 2015 | 74 | 0.030 |
Why?
| | Democratic Republic of the Congo | 1 | 2014 | 22 | 0.030 |
Why?
| | Pakistan | 1 | 2014 | 73 | 0.030 |
Why?
| | Immunoblotting | 1 | 2014 | 283 | 0.030 |
Why?
| | Dietary Sucrose | 1 | 2013 | 45 | 0.030 |
Why?
| | Transcriptome | 1 | 2019 | 725 | 0.030 |
Why?
| | Prediabetic State | 1 | 2016 | 219 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 1796 | 0.030 |
Why?
| | Fructose | 1 | 2013 | 100 | 0.030 |
Why?
| | STAT3 Transcription Factor | 1 | 2014 | 173 | 0.030 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 249 | 0.030 |
Why?
| | Cross-Over Studies | 1 | 2014 | 440 | 0.030 |
Why?
| | Carbon Isotopes | 1 | 2012 | 111 | 0.020 |
Why?
| | Leucine | 1 | 2012 | 102 | 0.020 |
Why?
| | Proteolysis | 1 | 2012 | 142 | 0.020 |
Why?
| | Mammary Glands, Animal | 1 | 2012 | 117 | 0.020 |
Why?
| | Cattle | 1 | 2014 | 920 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2014 | 1144 | 0.020 |
Why?
| | Pyruvate Dehydrogenase Complex | 1 | 2011 | 8 | 0.020 |
Why?
| | Pregnancy Outcome | 1 | 2013 | 337 | 0.020 |
Why?
| | Milk | 1 | 2012 | 124 | 0.020 |
Why?
| | Hep G2 Cells | 1 | 2011 | 60 | 0.020 |
Why?
| | Triiodothyronine | 1 | 2011 | 42 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2018 | 3003 | 0.020 |
Why?
| | Cell Respiration | 1 | 2011 | 74 | 0.020 |
Why?
| | Adipocytes, Brown | 1 | 2010 | 6 | 0.020 |
Why?
| | Cytogenetic Analysis | 1 | 2010 | 29 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 3329 | 0.020 |
Why?
| | Disease Susceptibility | 1 | 2012 | 316 | 0.020 |
Why?
| | Acetylation | 1 | 2011 | 211 | 0.020 |
Why?
| | Motor Activity | 1 | 2014 | 640 | 0.020 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2008 | 27 | 0.020 |
Why?
| | Somatostatin | 1 | 2008 | 52 | 0.020 |
Why?
| | Cell Lineage | 1 | 2010 | 309 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 4410 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 740 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 146 | 0.020 |
Why?
| | Liver Glycogen | 1 | 2007 | 17 | 0.020 |
Why?
| | Oncogene Protein v-akt | 1 | 2007 | 26 | 0.020 |
Why?
| | Absorptiometry, Photon | 1 | 2008 | 224 | 0.020 |
Why?
| | Hyperinsulinism | 1 | 2008 | 103 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2007 | 522 | 0.020 |
Why?
| | Protein Kinases | 1 | 2008 | 307 | 0.020 |
Why?
| | Biomedical Research | 1 | 2012 | 585 | 0.020 |
Why?
| | Glycogen | 1 | 2006 | 51 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2012 | 2765 | 0.020 |
Why?
| | Binding Sites | 1 | 2008 | 1168 | 0.020 |
Why?
| | Organ Size | 1 | 2006 | 436 | 0.020 |
Why?
| | Sex Factors | 1 | 2010 | 1715 | 0.020 |
Why?
| | Fever | 1 | 2006 | 280 | 0.010 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2006 | 386 | 0.010 |
Why?
| | Hypoglycemia | 1 | 2007 | 387 | 0.010 |
Why?
| | United States | 1 | 2018 | 12183 | 0.010 |
Why?
| | Aged | 1 | 2016 | 19074 | 0.010 |
Why?
| | Mutation | 1 | 2008 | 3346 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2014 | 12551 | 0.010 |
Why?
| | Middle Aged | 1 | 2016 | 26737 | 0.010 |
Why?
|
|
Friedman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|